REGN
$816.10+1.04%
as of close, Oct 27, 2026
☾ AH $816.10 +1.04%
Regeneron Pharmaceuticals Inc. total returns by year (including dividends)
As of market close, Oct 27, 2026
Regeneron Pharmaceuticals Inc. total returns by year (1992–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $771.87 | $816.10 | 0.4% | +6.1% | |
| 2025 | $712.33 | $771.87 | 0.6% | +9.0% | |
| 2024 | $878.29 | $712.33 | 0.0% | -18.9% | |
| 2023 | $721.49 | $878.29 | 0.0% | +21.7% | |
| 2022 | $631.52 | $721.49 | 0.0% | +14.2% | |
| 2021 | $483.11 | $631.52 | 0.0% | +30.7% | |
| 2020 | $375.48 | $483.11 | 0.0% | +28.7% | |
| 2019 | $373.50 | $375.48 | 0.0% | +0.5% | |
| 2018 | $375.96 | $373.50 | 0.0% | -0.7% | |
| 2017 | $367.09 | $375.96 | 0.0% | +2.4% | |
| 2016 | $542.87 | $367.09 | 0.0% | -32.4% | |
| 2015 | $410.25 | $542.87 | 0.0% | +32.3% | |
| 2014 | $275.24 | $410.25 | 0.0% | +49.1% | |
| 2013 | $171.07 | $275.24 | 0.0% | +60.9% | |
| 2012 | $55.43 | $171.07 | 0.0% | +208.6% | |
| 2011 | $32.83 | $55.43 | 0.0% | +68.8% | |
| 2010 | $24.18 | $32.83 | 0.0% | +35.8% | |
| 2009 | $18.36 | $24.18 | 0.0% | +31.7% | |
| 2008 | $24.15 | $18.36 | 0.0% | -24.0% | |
| 2007 | $20.07 | $24.15 | 0.0% | +20.3% | |
| 2006 | $15.90 | $20.07 | 0.0% | +26.2% | |
| 2005 | $9.21 | $15.90 | 0.0% | +72.6% | |
| 2004 | $14.71 | $9.21 | 0.0% | -37.4% | |
| 2003 | $18.51 | $14.71 | 0.0% | -20.5% | |
| 2002 | $28.16 | $18.51 | 0.0% | -34.3% | |
| 2001 | $35.27 | $28.16 | 0.0% | -20.1% | |
| 2000 | $12.75 | $35.27 | 0.0% | +176.6% | |
| 1999 | $7.38 | $12.75 | 0.0% | +72.9% | |
| 1998 | $8.56 | $7.38 | 0.0% | -13.9% | |
| 1997 | $16.13 | $8.56 | 0.0% | -46.9% | |
| 1996 | $12.75 | $16.13 | 0.0% | +26.5% | |
| 1995 | $3.00 | $12.75 | 0.0% | +325.0% | |
| 1994 | $15.50 | $3.00 | 0.0% | -80.6% | |
| 1993 | $12.00 | $15.50 | 0.0% | +29.2% | |
| 1992 | $18.13 | $12.00 | 0.0% | -33.8% |
- Annualized
- +12.5%
- 1992–2026
- Average year
- +28.8%
- 34 full years
- Best year
- +325.0%
- 1995
- Worst year
- -80.6%
- 1994
- Positive years
- 22/34
- 65% up
Annualized (CAGR)
+12.5%
1992–2026
Average year
+28.8%
34 full years
Best year
+325.0%
1995
Worst year
-80.6%
1994
Positive years
22/34
65% up
Total return by period#
Annual
-300%-200%-100%0%100%200%300%
1992-34%'92
1993+29%
1994-81%
1995+325%'95
1996+26%
1997-47%
1998-14%'98
1999+73%
2000+177%
2001-20%'01
2002-34%
2003-21%
2004-37%'04
2005+73%
2006+26%
2007+20%'07
2008-24%
2009+32%
2010+36%'10
2011+69%
2012+209%
2013+61%'13
2014+49%
2015+32%
2016-32%'16
2017+2.4%
2018-0.65%
2019+0.53%'19
2020+29%
2021+31%
2022+14%'22
2023+22%
2024-19%
2025+9.0%'25
2026+6.1%
Methodology#
Total returns, dividends reinvested, measured on REGN. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Regeneron Pharmaceuticals Inc.'s average annual return?
- Since 1992, Regeneron Pharmaceuticals Inc. (REGN) has returned about 12.5% a year (the compound annual growth rate) and an average calendar-year return of 28.8%.
- What were Regeneron Pharmaceuticals Inc.'s best and worst years?
- Over 1992–2026, the best year was 1995 (+325.0%) and the worst was 1994 (-80.6%).
- How often is Regeneron Pharmaceuticals Inc. up in a year?
- 22 of the 34 full years since 1992 were positive — about 65% of the time.
More on Regeneron Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100